Evidence map›Paper›PMID 25831514›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives metabolic reprogramming in T lymphocytes.

Tim Willinger, Matthew Staron, Shawn M Ferguson, Pietro De Camilli, Richard A Flavell

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. DNA-directed assembly of multivalent lipid nanoparticles for targeted T cell gene delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. NFκB and JNK pathways mediate metabolic adaptation upon ESCRT-I deficiency.Cellular and molecular life sciences : CMLS · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.Journal of experimental & clinical cancer research : CR · 2023
    Review
  12. Article
  13. Review
  14. Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR".International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Mechanisms and functions of endocytosis in T cells.Cell communication and signaling : CCS · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tim WillingerDepartments of Immunobiology and richard.flavell@yale.edu tim.willinger@yale.edu.
Matthew StaronDepartments of Immunobiology and.
Shawn M FergusonCell Biology, Program in Cellular Neuroscience, Neurodegeneration and Repair, and.
Pietro De CamilliCell Biology, Program in Cellular Neuroscience, Neurodegeneration and Repair, and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520.
Richard A FlavellDepartments of Immunobiology and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520 richard.flavell@yale.edu tim.willinger@yale.edu.
Yale University · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Prolonged T-cell receptor (TCR) signaling is required for the proliferation of T lymphocytes. Ligation of the TCR activates signaling, but also causes internalization of the TCR from the cell surface. How TCR signaling is sustained for many hours despite lower surface expression is unknown. Using genetic inhibition of endocytosis, we show here that TCR internalization promotes continued TCR signaling and T-lymphocyte proliferation. T-cell-specific deletion of dynamin 2, an essential component of endocytosis, resulted in reduced TCR signaling strength, impaired homeostatic proliferation, and the inability to undergo clonal expansion in vivo. Blocking endocytosis resulted in a failure to maintain mammalian target of rapamycin (mTOR) activity and to stably induce the transcription factor myelocytomatosis oncogene (c-Myc), which led to metabolic stress and a defect in cell growth. Our results support the concept that the TCR can continue to signal after it is internalized from the cell surface, thereby enabling sustained signaling and cell proliferation.

Indexed as

EndocytosisSignal TransductionAnimalsAntibodies, MonoclonalAutophagyCell MembraneCell ProliferationDynamin IIGene Expression RegulationImmunotherapyMiceMice, KnockoutPhosphorylationProto-Oncogene Proteins c-mycReceptors, Antigen, T-CellT-LymphocytesAntibodies, MonoclonalDynamin IImTOR protein, mouseProto-Oncogene Proteins c-mycReceptors, Antigen, T-CellTOR Serine-Threonine KinasesendocytosismetabolismproliferationT-cell receptor

Identifiers

PMID25831514
PMCPMC4394306
OpenAlexW1983068565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.